Related Experiment Video
Updated: Sep 3, 2025

10:03
Author Spotlight: Understanding Cytokine-Induced Cell Death in Intestinal Epithelial Cells Using Human Organoids
Published on: August 2, 2024
1.6K
Non-Canonical Programmed Cell Death in Colon Cancer
Bingchen Pan1, Bowen Zheng1, Chengzhong Xing1
1Department of Anus and Intestine Surgery, First Affiliated Hospital of China Medical University, Shenyang 110001, China.
Cancers
|July 27, 2022
Summary
Programmed cell death (PCD) encompasses various cell suicide pathways. This review explores how non-canonical PCD types influence colon cancer development, treatment, and drug resistance.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Programmed cell death (PCD) is a fundamental biological process crucial for development and tissue homeostasis.
- Non-canonical PCD pathways, distinct from apoptosis, are increasingly recognized for their roles in disease.
- Colon cancer remains a significant global health challenge, driven by complex genetic and environmental factors.
Purpose of the Study:
- To systematically review the involvement of diverse non-canonical programmed cell death (PCD) modalities in colon cancer.
- To elucidate the association between non-canonical PCD and colon cancer initiation, progression, prevention, and prognosis.
- To explore the therapeutic potential of targeting non-canonical PCD in drug-resistant colon cancer.
Main Methods:
- Comprehensive literature review of studies investigating non-canonical PCD in colon cancer.
- Analysis of signaling pathways and molecular mechanisms underlying various non-canonical PCD types (e.g., ferroptosis, pyroptosis, necroptosis).
- Synthesis of evidence on the interplay between different non-canonical PCD pathways and their collective impact on colon cancer.
Main Results:
- Multiple non-canonical PCD types, including ferroptosis, pyroptosis, necroptosis, and others, are implicated in colon cancer pathogenesis.
- These pathways influence tumor initiation, growth, metastasis, and response to therapy.
- Interactions among different non-canonical PCD pathways modulate colon cancer progression and drug resistance.
Conclusions:
- Non-canonical PCD pathways represent promising therapeutic targets for colon cancer treatment.
- Understanding the complex interactions of these pathways is critical for developing effective anti-cancer strategies.
- Targeting non-canonical PCD offers a potential avenue for overcoming drug resistance in colon cancer.
Related Concept Videos
Overview of Cell Death
7.6K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
7.6K
The Extrinsic Apoptotic Pathway
6.6K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.6K
The Intrinsic Apoptotic Pathway
6.8K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.8K
Necrosis
4.8K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.8K
Apoptosis
11.9K
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
11.9K
Autophagic Cell Death
3.5K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.5K

